Neal James R
CIK 0001600865
CEODirector
Filings
18
Latest Apr 2, 2026
Issuers covered
5
Showing
18 of 18
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 100% | +15.1% | +17.0% | +19.7% | +6.9% |
| 90 days | 3 | 100% | +36.7% | +37.7% | +37.9% | +34.5% |
| 180 days | 3 | 100% | +36.5% | +37.5% | +37.7% | +34.2% |
| 365 days | 3 | 100% | +32.0% | +34.0% | +34.3% | +27.7% |
Issuers
Companies where Neal James R has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| PCSA | Processa Pharmaceuticals, Inc. | 6 | Apr 2, 2026 |
| AKTX | Akari Therapeutics PLC | 5 | Mar 16, 2026 |
| PALI | Palisade Bio, Inc. | 4 | Feb 13, 2024 |
| PKBO | Peak Bio, Inc. | 2 | Nov 18, 2024 |
| XOMA | Xoma Corp | 1 | Mar 23, 2022 |
All filings
18 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|